The “Clariti 1-day Multifocal 3 Add” uses different optical designs for low, medium and high plus powers and offers a wider sphere range than its predecessor.
A new low-dose pilocarpine agent can be administered up to twice a day for maximum duration of effect. It is hoped to result in fewer adverse effects than Vuity.
A panel agreed on many aspects of pre-op and intraoperative decision-making. They disagreed, however, when considering issues related to lens selection.